While 5-25% of the 0-3 year-old population is at risk for developmental delay, few of these children receive regular developmental screenings by clinicians. The use of the Ages & Stages Questionnaire (ASQ), a parent-completed developmental screen, has previously been shown to be a cost-effective screening tool with high sensitivity and specificity when compared to professionally-administered measures such as the Bayley, and may help increase screening rates. As part of a randomized clinical trial, I-CHAP/MHRA (the Child Find component of New York City's Early Intervention Program) is comparing screening rates using ASQ's mailed to families at 2-6 month intervals vs. traditional provider-administered Denver II in a sample of 269 at-risk children attending two inner city primary care sites serving poor African-American and Latino families. Preliminary analyses show that over 70% of the ASQ's are returned in comparison to a 20% screening rate with the Denver II. The presentation will provide data on the overall study group and subgroups defined by risk status. Additionally, the concordance of ASQ results with Bayley II's conducted as part of Early Intervention evaluations will be examined.
Learning Objectives: At the conclusion of the session, the participant will 1) be familiar with the role of Part C Child Find programs of assuring developmental monitoring of at-risk children 2) recognize the advantages of the Ages and Stages Questionnaire (ASQ) 3) recognize the effectiveness of using the ASQ in urban settings
Keywords: Screening, High Risk Infants
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: Maternal and Child Health Bureau
I have a significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.
Relationship: Grant